ERYTECH kündigt Veröffentlichung seiner Phase-2b-Studie zu Eryaspase bei metastatischem Bauchspeicheldrüsenkrebs im European Journal of Cancer an

Frank Burrell
Scientific Storytelling

David Linetsky
Point-of-Care Marketing

Joey Cohen
Medication Adherence

Pat Purcell
Meeting Engagement

Brenda Snow
Authentic Patient Voice

Suma Ramadas, PhD
Medical Affairs

Paul Theisen
Patient Acquisition

Daniel Sontupe
Market Access

Stacey Gandler
Brand Nourishment

Matt Turner
Patient Affordability

Amy Giles
Increasing Engagement

Matthew Durham
Omnidynamic Marketing

Liz Kane
Impactful Strategy

Bud Bilanich
Success Coach